BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/13/2023 8:46:32 AM | Browse: 525 | Download: 1364
 |
Received |
|
2023-03-24 10:03 |
|
Peer-Review Started |
|
2023-03-24 10:06 |
|
First Decision by Editorial Office Director |
|
2023-05-13 23:51 |
|
Return for Revision |
|
2023-05-13 23:51 |
|
Revised |
|
2023-05-25 18:58 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-06-21 02:58 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-06-21 08:58 |
|
Articles in Press |
|
2023-06-21 08:58 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-07-04 09:21 |
|
Publish the Manuscript Online |
|
2023-07-13 08:46 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Roman Maslennikov, Aliya Alieva, Elena Poluektova, Yury Zharikov, Andrey Suslov, Yana Letyagina, Ekaterina Vasileva, Anna Levshina, Evgenii Kozlov and Vladimir Ivashkin |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Roman Maslennikov, MD, PhD, Academic Editor, Assistant Professor, Doctor, Doctor, Professor, Department of Internal Medicine, Gastroenterology and Hepatology, Sechenov University, Pogodinskaya str., 1, bld. 1, Moscow 119435, Russia. mmmm00@yandex.ru |
| Key Words |
Cirrhosis; Muscle; Fragility; Liver; Microbiota; Microbiome |
| Core Tip |
Sarcopenia is common in patients with cirrhosis and is associated with a poor prognosis. Although the pathogenesis of this disorder has not been fully elucidated, a disordered gut-muscle axis probably plays an important role. Drugs that target the gut microbiota positively affect most links of the compromised gut-muscle axis in patients with cirrhosis. However, they have not yet been investigated in randomized controlled trials specifically for the treatment and prevention of sarcopenia in patients with cirrhosis. |
| Publish Date |
2023-07-13 08:46 |
| Citation |
Maslennikov R, Alieva A, Poluektova E, Zharikov Y, Suslov A, Letyagina Y, Vasileva E, Levshina A, Kozlov E, Ivashkin V. Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota. World J Gastroenterol 2023; 29(27): 4236-4251 |
| URL |
https://www.wjgnet.com/1007-9327/full/v29/i27/4236.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v29.i27.4236 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
